Literature DB >> 8856119

Effect of combined B1 and B2 kinin receptor blockade in porcine endotoxin shock.

M Siebeck1, E Spannagl, M Schorr, B Stumpf, H Fritz, E T Whalley, J C Cheronis.   

Abstract

In order to investigate the contribution of kinin receptor antagonism in the treatment of LPS-induced shock we conducted a randomized study with anaesthetized piglets. Before randomization the animals were stratified according to predetermined health criteria under baseline conditions. One group of control animals received LPS from S. abortus equi (2 micrograms/kg/h i.v. for 8 h) and saline (Group 1). Another group received LPS and the B2 antagonist CP-0127 (3 micrograms/kg/min), beginning 1 h after LPS (Group 2). Group 3 received LPS and the B2 antagonist in the aforementioned doses, and the B1 antagonist Leu9-des-Arg10-kallidin (3 micrograms/kg/min), also beginning 1 h after LPS. Overall survival figures after 8 h of LPS infusion were: Group 1, 10/22 (45%); Group 2, 10/17 (59%); Group 3, 10/28 (36%). Fifty percent (29/58) of animals that were healthy at baseline survived, but only 11% (1/9) of sick animals survived (Log Rank p = 0.0001). In the subset of healthy animals, survival rates for Groups 2 and 3 were 77% and 38%, respectively (p = 0.0519). It appears, therefore, that B2 blockade attenuates LPS-induced mortality whereas additional B1 blockade seems to reverse these beneficial effects. This suggests that in this animal model the B1 receptor does not serve the same purpose as the B2 receptor, and that up-regulation of B1 receptors during LPS shock may be an important mechanism of host defence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856119     DOI: 10.1016/0162-3109(96)00060-4

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  5 in total

1.  Endotoxin sensitization to kinin B(1) receptor agonist in a non-human primate model: haemodynamic and pro-inflammatory effects.

Authors:  D deBlois; R A Horlick
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  A primary role for kinin B1 receptor in inflammation, organ damage, and lethal thrombosis in a rat model of septic shock in diabetes.

Authors:  N Tidjane; A Hachem; Y Zaid; Y Merhi; L Gaboury; J-P Girolami; R Couture
Journal:  Eur J Inflamm       Date:  2015-04-01       Impact factor: 0.466

Review 3.  Vascular endothelial dysfunction and pharmacological treatment.

Authors:  Jin Bo Su
Journal:  World J Cardiol       Date:  2015-11-26

Review 4.  Function and structure of bradykinin receptor 2 for drug discovery.

Authors:  Jin-Kang Shen; Hai-Tao Zhang
Journal:  Acta Pharmacol Sin       Date:  2022-09-08       Impact factor: 7.169

5.  A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase.

Authors:  Viktor Brovkovych; Yongkang Zhang; Svitlana Brovkovych; Richard D Minshall; Randal A Skidgel
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.